Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Pruitt

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Blood|February 11, 2012
Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory functionJens Dannull, Tristan Schneider, Walter T Lee, et al.
Transplantation|February 27, 1996
Functional activity of anti-C6 antibodies elicited in C6-deficient rats reconstituted by liver allografts. Ability to inhibit hyperacute rejection of discordant cardiac xenograftsR B Brauer, W M Baldwin, D Wang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 24, 2004
Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cellsMatthew F Kalady, Mark W Onaitis, Sirisha Emani, et al.
The Journal of Surgical Research|January 21, 2004
Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicityMatthew F Kalady, Mark W Onaitis, Sirisha Emani, et al.
The Journal of Surgical Research|June 19, 2002
Enhanced dendritic cell antigen presentation in RNA-based immunotherapyMatthew F Kalady, Mark W Onaitis, Karen M Padilla, et al.
Surgery|August 30, 2003
CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapyMark W Onaitis, Matthew F Kalady, Sirisha Emani, et al.
Transplantation Proceedings|April 11, 1992
Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejectionS K Pruitt, W M Baldwin, H C Marsh, et al.
The Journal of Surgical Research|July 30, 2013
Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccinationChunrui Tan, Jens Dannull, Smita K Nair, et al.
Transplantation|November 11, 1991
The effect of soluble complement receptor type 1 on hyperacute xenograft rejectionS K Pruitt, W M Baldwin, H C Marsh, et al.
Blood|September 15, 2007
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunityJens Dannull, Diem-Thu Lesher, Robert Holzknecht, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Blood|February 11, 2012
Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory functionJens Dannull, Tristan Schneider, Walter T Lee, et al.
Transplantation|February 27, 1996
Functional activity of anti-C6 antibodies elicited in C6-deficient rats reconstituted by liver allografts. Ability to inhibit hyperacute rejection of discordant cardiac xenograftsR B Brauer, W M Baldwin, D Wang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 24, 2004
Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cellsMatthew F Kalady, Mark W Onaitis, Sirisha Emani, et al.
The Journal of Surgical Research|January 21, 2004
Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicityMatthew F Kalady, Mark W Onaitis, Sirisha Emani, et al.
The Journal of Surgical Research|June 19, 2002
Enhanced dendritic cell antigen presentation in RNA-based immunotherapyMatthew F Kalady, Mark W Onaitis, Karen M Padilla, et al.
Surgery|August 30, 2003
CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapyMark W Onaitis, Matthew F Kalady, Sirisha Emani, et al.
Transplantation Proceedings|April 11, 1992
Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejectionS K Pruitt, W M Baldwin, H C Marsh, et al.
The Journal of Surgical Research|July 30, 2013
Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccinationChunrui Tan, Jens Dannull, Smita K Nair, et al.
Transplantation|November 11, 1991
The effect of soluble complement receptor type 1 on hyperacute xenograft rejectionS K Pruitt, W M Baldwin, H C Marsh, et al.
Blood|September 15, 2007
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunityJens Dannull, Diem-Thu Lesher, Robert Holzknecht, et al.
Pageof 9